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Partitioning of energy in the interaction of non-intercalating antibiotics (netropsin, netropsin without its 
cationic ends and two analogs of distamycin A) with different base sequences of B-DNA is studied here 
by the atom-atom potential technique and geometry optimization procedures. The results show that elec- 
trostatic forces contribute substantially to the stabilization energy as well as to the sequence specificity. The 
hydrogen-bonding term is also sequence specific and is significant in properly orienting the drug molecule. 
Relative roles of the hydrogen bonding and electrostatic interac~ons depend on the dielectric property of 
the medium. 
DNA recognition Netrapsin Distamycin A analog 
1. INTRODUCTION 
Antitumour antibiotics of the netropsin, 
distamycin class bind to DNA molecule in the 
minor groove and exhibit marked conformation 
and base specificity [I-IO], which is dependent on 
the surrounding medium. For example, under high 
salt conditions, poly d(GC), . d(GC), does not bind 
to netropsin whereas lowering the salt concentra- 
tion enables it to bind 141. These antibiotics have 
been the target of extensive physicoche~~l 
studies in the last couple of years because they 
serve as ideal ‘models’ for studying recognition of 
DNA by repressor proteins and enzymes [ 1 l- 151. 
The aim behind this work is to study the 
m~hanism of s~uence-specific recognition of 
DNA by non-intercalating antitumour antibiotics 
in the minor groove in changing medium. Rigorous 
computer model building with energy minimiza- 
tion based on atom-atom potentials is used. Parti- 
tioning of energy contributions and its variation 
with dielectric constant are studied here for netrop- 
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sin without its cationic tails, netropsin, distamycin 
A analogs - distamycin 2 and another in which the 
formamide is replaced by nitro and the propyl- 
~i~~~~ chain is modified as shown in fig.i 
(Net 1, Net 2, Dist A An., Dist 2); interactions 
with different base sequences d(A)s - d(Vs; 
d(TATAT) . d(ATATA); d(AGAGA) * d(TCTCT); 
and d(C)5 . d(G)5 (DNA 1, DNA 2, DNA 3, DNA 
4). 
2. EXPERIMENTAL 
2.1. Data preparation 
Starting geometries for the drug molecules were 
taken from their crystallographic data [16,17]. 
DNA sequences in the B-form were generated on 
the basis of fiber X-ray diffraction data obtained 
by Arnott et al. [18]. Partial atomic charges were 
generated by the CNDO/II method [19]. Other 
parameters for the energy calculations were taken 
from Momany et al. [20]. 
2.2. Geometry optimization 
First, 3 target points (TPs) were fixed with 
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respect o the DNA molecule. They can be specific 
hydrogen-bonding positions. Three points were 
then chosen on the drug molecule as attacking 
points (APs). API was first superimposed on TPr 
and AP2-API were then made colinear with 
TP2-TPr. In the next step AP3 was brought closest 
to the plans described by TPr, TP2, TP3. Undesir- 
able short contacts between the drug molecule and 
DNA were then removed by giving small rotations 
around single bonds in the drug molecule. This 
provides the starting drug geometry. This was 
followed by series of geometry operations to 
minimize the interaction energy. These operations 
consist of (i) rotation around helical axis, (ii) rota- 
tion around a bond, of either whole or part of the 
molecule, (iii) gliding along the helix, (iv) moving 
in or out of the groove, (v) moving towards a par- 
ticular strand of the helix. The potential energy 
function consisting of conformation as we11 as in- 
teraction terms was calculated using the monopole 
Heltcal DXIS 
approximation method and non-bonded, electro- 
static, polarization and hydrogen-bonding con- 
tributions between interacting groups (phosphate 
sugar, bases, amides, rings, cationic tails, etc.) 
were computed. The group-group potential was 
then reorganised to observe individual contribu- 
tions. 
3. RESULTS AND DISCUSSION 
3.1. Drug-L&VA model 
Fig.1 depicts the top view (in a plane perpen- 
dicular to the helical axis) for Net 1, Net 2, Dist A 
An. and Dist 2, whereas the drug position along 
with DNA 1 in the B-form is shown in fig.2. 
It can be seen that all 4 drug molecules are snug- 
ly fitted in the minor groove with C5H, CrrH and 
amides N4H, NsH, N&I of Net and GH, CroH 
and amides N3H and NsH of distamycin pointing 
to the floor of the groove and forming a concave 
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Fig.1. Top view of (I) Net 1, (II) Net 2, (III) Dist A An., (IV) Dist 2. (0) Position of hydrogen bonding. 
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Fig.2. Side view of Dist A An. with DNA 1. Bases and 
hydrogens are omitted for the sake of clarity. 
surface. The 2 pyrrole rings are oriented with 
respect to each other at an angle ranging from 18 
to 20” which can be compared with about 20 and 
4.5” in crystallographic studies of netropsin and 
Dist A An. [ 16,171 and 33” in a complex of netrop- 
sin with CGCGAATTCGCG [13]. The hydrogen 
bonds are observed between N4H, N,jH of netrop- 
sin and N3H, NsH of distamycin with Ns of 
purines and 02 of pyramidines. Bifurcated 
hydrogen bonds were observed for all 4 drugs with 
DNA 1 and DNA 2. The drug molecule could bind 
parallel or antiparallel to the backbone with a very 
small (4.5 kcal/mol in the case of Net 2 with DNA 
1) expenditure of energy. The general geometric 
features of our model are quite similar to the 
crystallographic model of Dickerson et al. [ 131 and 
agree with the NMR data [14], which shows the 
validity of the adopted procedure. The only dif- 
ference between our model and that of Dickerson 
et al. was in the placement of the drug about the 
dyad axis. Drug was slightly shifted towards one 
strand in our model. This was because the minor 
groove in the B-DNA fiber diffraction data of Ar- 
nott et al. [ 18) is slightly wider compared to that of 
the model of Dickerson et al. 
3.2. Total interaction energy changes 
A summary of different energy contributions 
and energy break up for 2 strands is shown in table 
1 for Net 1, Net 2, Dist A An. and Dist 2 for bind- 
ing with DNA 1, DNA 2, DNA 3 and DNA 4 at 
6 = 4.0. It was observed that the drugs could also 
bind at the periphery of the groove where its posi- 
tion becomes locked in the local minima. Multiple 
binding positions were observed in some cases. 
Energy break up for these additional positions is 
also shown in table 1. The total interaction energy 
follows the order: DNA 1 = DNA 2 < DNA 3 < 
DNA 4, which is consistent with the binding con- 
stant for Net and Dist 2 obtained by Wartell et al. 
[4] and Gursky et al. [15]. It is also consistent with 
enthalpy measurements made by Zimmer et al. 
[21]. The relative binding order was: Net 2 > 
Dist 2 > Dist A An. > Net 1. Its direction agrees 
with the free energy change values for netropsin 
and Dist 2, viz. -12.3 and -2.91 kcal/mol [15, 
221. 
3.3. Analysis of energy partitioning for different 
values of dielectric constants 
The relative contributions by bases-amides, 
bases-rings, bases-tails, backbone-amides, back- 
bone-rings and backbone-tails for Net 1, Net 2, 
Dist A An. and Dist 2 with DNA 1, DNA 2, DNA 
3, DNA 4 are depicted in fig.3. 
The results show that in the case of netropsin, 
the major part (600/o) of the stabilization energy 
arises from the electrostatic interactions between 
the tails and backbone. Its contribution at f = 4.0 
in Dist 2 and Dist A An. is 42 and 0.5%, respec- 
tively. This term is susceptible to changes in dielec- 
tric constant and affects the binding constant. 
Depending on its weightage, it can be a major con- 
trolling factor in environment-based changes in the 
association constant as observed in the case of 
netropsin [4]. However, it is not sequence specific. 
Removal of the cationic tails will considerably 
reduce the changes in the binding energy caused by 
salt concentration variations. 
Sequence specificity arises due to systematic dif- 
ferences in the electrostatic contribution from 
base-ring and base-tail interactions. Hydrogen 
bonding assists in proper orientation of the drug. 
However, its net contribution to the free energy of 
interaction is small at e = 4.0. It shows a sequence- 
dependent variation from DNA 1 to DNA 4. Its 
relative role in sequence specificity depends on the 
nature of the drug and the environment. For those 
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Table 1 
Interaction energy (kcal/mol) Net 1, Net 2, Dist A An., Dist 2 with DNA 1, DNA 2, DNA 3, DNA 4 at 
6 = 4.0 
Strand Non Ele-pol Hydg Total 
I II 
Net 1 with 
DNA 1 
DNA 2 
DNA 3 
DNA 4 
Net 2 with 
DNA 1-I 
DNA l-11 
DNA 2-I 
DNA 2-11 
DNA 3-I 
DNA 3-11 
DNA 4-I 
DNA 4-H 
Dist A An. with 
DNA 1-I 
DNA l-11 
DNA 2 
DNA 3 
DNA 4 
Dist. 2 with 
DNA 1 
DNA 2 
DNA 3 
DNA 4 
- 36.544 - 31.588 
- 35.512 - 32.940 
- 31.418 - 19.786 
- 29.719 - 22.627 
- 145.955 
- 112.813 
- 146.644 
- 87.663 
- 137.006 
- 71.147 
- 128.628 
- 74.466 
- 110.769 
- 104.452 
- 106.947 
- 116.197 
- 96.355 
- 98.995 
- 81.686 
- 90.966 
- 42.320 - 31.001 
- 39.794 - 32.686 
- 41.821 - 34.132 
- 36.450 - 33.676 
- 34.708 - 34.260 
- 106.157 - 61.419 
- 107.868 - 60.075 
- 110.661 - 48.445 
- 105.171 - 44.121 
- 45.995 
-46.516 
- 31.719 
- 35.380 
- 29.998 
- 15.027 
- 30.175 
- 19.284 
- 28.539 
- 13.658 
- 33.503 
- 19.549 
- 44.923 
-43.699 
- 46.220 
-44.090 
- 46.960 
- 42.835 
- 42.873 
- 45.262 
- 49.753 
- 9.972 
- 9.373 
- 10.823 
- 10.426 
-215.009 
- 202.139 
-215.115 
- 184.576 
- 197.131 
- 156.485 
- 171.020 
- 145.882 
- 20.871 - 7.536 
- 19.419 - 9.361 
- 20.267 - 9.466 
- 18.252 - 7.784 
- 16.228 - 5.780 
- 121.137 
- 121.388 
- 110.668 
- 97.409 
- 12.408 
- 12.563 
- 8.662 
- 6.541 
- 8.357 
- 8.301 
- 7.692 
- 5.791 
- 3.605 
- 3.682 
- 3.176 
- 2.130 
- 68.132 
- 68.452 
- 51.204 
- 52.346 
- 253:365 
- 217.266 
- 253.591 
- 203.860 
- 233.362 
- 170.143 
- 210.315 
- 165.432 
- 73.330 
- 72.480 
- 75.953 
- 70.126 
- 68.968 
- 167.576 
- 167.943 
- 159.106 
- 149.292 
Strand I and strand II are total interaction energies with first and second strands. Other terms give respec- 
tively nonbonded (Non), electrostatic with polarization (Ele-pol), hydrogen bonding (Hydg) and total 
energies 
drugs which do not have cationic tails (Dist A An. 
and Net 1) it contributes 22 and 35070, respectively, 
to sequence specificity (6 = 4.0). This increases 
with increase in the dielectric constant. In contrast, 
for drugs with cationic tails such as Net 2 or Dist 
2, electrostatic interaction plays a central role in 
sequence-specific recognition as suggested by 
Lavery and Pullman [23]. 
Interesting interaction is shown by the amide 
groups. Negatively charged nitrogens show repul- 
sion by both phosphate oxygens as well as N3 and 
0~ of bases. Phosphate repulsion probably assists 
in guiding the drug to the floor of the groove, 
where it is held by other interactions. 
To sum up differences in the binding modes of 
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different drugs with DNA sequences arise due to 
an intricate balance between the energy contribu- 
tions mentioned above, each of which comprises a 
series of atom-atom contributions. Thus in the 
case of netropsin it is basically the electrostatic in- 
teraction with the DNA backbone and bases which 
leads to the free energy of association and 
specificity. The same holds true in the case of Dist 
2 with reduced magnitude. In Dist A An. the 
relative weightage of hydrogen bonding is greater. 
Geometric differences in the binding of the ring 
portions of these drugs are negligible. The tails 
have high mobility and adjust themselves ac- 
cording to their structure. Conformational 
changes in the drug molecule have been found to 
Volume 195, number 1,2 FEBS LETTERS 
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Fig.3. Partitioning of interaction energies of (a) Net 1, (b) Net 2, (c) Dist A An., (d) Dist 2 with DNA sequences. The 
curves depict average values for the change in dielectric constant between 4-20. Variations in electrostatic and polariza- 
tion terms are shown by vertical bars. 
affect these contributions ignificantly. Hence the 
conformation piays an equally important role in 
sequence specificity. 
Work on the effect of DNA backbone deforma- 
tions and of different ionic media on DNA 
recognition by these drugs is in progress. 
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